FDA Investigator Evelyn Taha

Evelyn Taha has inspections in 20 countries as of 13 Nov 2023. Evelyn Taha has collaborated with a combinined 4197 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
335
Last Inspection Date:
13 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
100006787
Country:
United States of America, Germany, Philippines, Switzerland, United Kingdom of Great Britain and Northern Ireland, Sweden, Ireland, Taiwan, Spain, Netherlands, China, France, Italy, Denmark, Finland, Japan, Malaysia, Czechia, Norway
Co-Investigator(s):
A Williams, Aaron L Dunbar, Adaliz Santaliz Cruz, Ademola O Daramola, Akbar J Zaidi, Alia Legaux, Alice S Tsao, Althea A Williams, Amber D Brodas, Amy Constantine, Amy Kim, Amy W Mai, Amy W Yan Mai, Andrew J Garufi, Andrew M Abramowitz, Angela Jourdain, Anthony N Onianwa, Arduino Frankovic, Arthur S Williams, Jr, Barbara J Rincon, Barbara Paul, Benjamin W Anderson, Benton M Ketron, Brandon L Mariner, Brittani N Franklin, Burnell M Henry, Cara M Minelli, Carl A Huffman, III, Carl E Lovrich, Carolyn J Cook, Catherine J Laufmann, CDR Sean T Creighton, Charanjeet Jassal, Charisse K Green, Charles I Ann, Charles L Larson, Charles N Dupont, Cheryl G Scott, Christian Parra, Christine M Parmentier, Christopher A Demitrius, Dave M Deroche, David J Gallant, David M Mcnew, David P Vanhouten, David R Delucia, Demitria J Xiradakis, Denise L Terzian, Dipesh K Shah, Donna Ltartaglino Besone, Dorothy W Lee, Douglas G Ng, Dr. Barbara D Paul, PhD, Dr. Gang Wang, PhD, Dr. Nallaperumal Chidambaram, Elizabeth B Griffin, Elizabeth M Jacobson, Emily A Walters, Eric J Reisenauer, Eric M Padgett, Evelyn Taba, Evelyn Tama, Fatima Bassa, Felix J Marrero, Francis A Guidry, Frank J Marciniak, Frank Verni, Frederick Razzaghi, Gayle J Gehrman, Gene D Arcy, George C Amedro, George G Calafactor, George M Ibrahim, George T Allen, Jr, Gloria E Parra, Gloria Parra, Gregson A Joseph, Harperd, Harry J Brewer, Haydee B Romero, Hoimay Chan, Iram R Hassan, PhD, Irina Gaberman, Jacqueline Mdiaz Albertini, Jacqueline S Warner, James A Beaulieu, James D Bridges, James D Planchon, James E Szelc, James M Odonnell, James M Simpson, James P Finn, James P Mcreavey, James R Fleckenstein, James R Montero, Jane Chen, Janete F Guardia, Jeanette L Mcginnis, Jennifer A Bazergui, Jennifer L Custodio, Jennifer Macmillan, Jennifer S Ness, Jocelyn C Turner, John E Aghadia, Joseph O Sullivan, Joseph S Tomao, Joshua J Silvestri, Joy P Matthias, Juanita P Versace, Karan L Blum, Karen A Coleman, Karen L Kosar, Karl D Hezel, Kathryn A Nagy, Kellie Leveille, Kelvin Cheung, Kenneth S Boehnen, Kent C Hermann, Kerun Hardeo, Kevin A Gonzalez, Kim M Downing, Kimberley A Gordon, Kimberley A Ricketts, Kinh Q Mac, Kip J Hanks, Kwong P Lee, L Gnnmassimia Massimilla, PharmD, Laiza V Garcia, Lara Schankweiler, Laura M Howard, Laura Schankweiler, Lauren E Blaser, Leena Thomas, Leo J Lagrotte, Linda Agregory Duty, Linda M Sacco, Lisa M Lopez, Lisa Mathew, Lori A Carr, Lori S Lawless, LTJG Matthew R Palo, Lydia S Chan, Marc S Neubauer, Marianna Sala Rhatigan, Mark R Mcclain, Marla A Cassidy, Marlene L Davis, Mary T Carden, Matthew D Schnittker, Matthew J Sienko, Mercedes G Castillo, Mercy O Quagraine, Meredith P Soehl, Investigator, Miaja Umaedi, Michael A Charles, Michael G Sinkevich, Michael J Nerz, Michael R Dominick, Michael W Burd, Michelle J Glembin, Mohammad Heidaran, PhD, Mpris Inspector, Nancy L Neiger, Natasha N Mccants, Nicholas C Mendiola, Norman Wong, Pal S Mayasandra, Patricia A Clark, Patricia A Mcilroy, Patty P Kaewussdangkul, Paul E Stein, Paul Mouris, Pauline N Logan, Perry H Gambrell, Peter Abel, Preston M Lee, Rachael A Moliver, Ralph Jerndal, Raymond T Oji, Rebecca Rodriguez, Richard Jay Tucker, RS, Richard L Rutherford, Robert C Steyert, Robert G Ruff, Robert W Mcdowell Jr, Ronald Ifraimov, Roy Baby, Russ E Davis, Samina S Khan, Samuel Eskenazi, Samuel T Walker, Sandra D Thompson, Sara M Onyango, Sarah A Meehan, Sarah A Wangseng, Sarah Forney, Satheesh Thomas, Shannon A Gregory, Shaquenta Y Perkins, Shreya Shah, Simone E Pitts, Stanley B Eugene, BS, BME, Stanley Noneze, Stephanie T Durso, Stephen C Smith, Stephen D Eich, Stephen R Souza, Steven J Libal, Steven R Ziser, Talmane J Fisher, Tamara Brey, Tania E Vizcaino, Tara K Carmody, Teresa Jimenez, Terry C Kimball, Thai D Truong, Thai T Duong, Thomas E Friel, Thomas J Mooney, Thomas P Hansen, Timothy G Philips, Tony T Yang, Valerie A Potopsingh, Valerie Grecek Trinh, Valerie J Grecek Trinh, Valerie Trinh, Victor Spanioli, Vivian Garcia, Viviana Matta, Wendy M Stone, William C Lubas, William D Tingley, William J Leonard, William V Thompson, Xiaokuang Lai, PhD, Yehualashet A Gessesse, Yong Hu, Yvonne E Lozano, Yvonne M Santiago

Evelyn Taha's Documents

Publish Date Document Type Title
May, 2015 FDA 483 Fonar Corporation - Form 483, 2015-05-22
January, 2002 FDA 483 NYU Hospitals Center - Form 483, 2002-01-18
July, 2009 FDA 483 Merck Kommanditgesellschaft auf Aktien - Form 483, 2009-08-21
May, 2013 FDA 483 New York Blood Center, Inc. - Form 483, 2013-05-07
July, 2014 FDA 483 Digio2 International Co., Ltd - Form 483, 2014-07-10
November, 2012 FDA 483 Linet Spol. S.r.o. - Form 483, 2012-11-01
October, 2003 EIR Medicom A.S. - EIR, 2003-10-02
March, 2000 FDA 483 New York Blood Center Enterprises - Form 483, 2000-03-20
February, 2012 FDA 483 European Custom Manufacturing B.V/ Medical Concepts Europe - Form 483, 2012-02-16
February, 2003 FDA 483 New York Blood Center Enterprises - Form 483, 2003-02-28
February, 2003 FDA 483 Response New York Blood Center Enterprises - Form 483R, 2003-04-21
April, 2001 EIR New York Blood Center Enterprises - EIR, 2001-04-03
March, 2015 FDA 483 Novus Scientific Ab - Form 483, 2015-03-12
April, 2002 EIR Kings County Hospital - EIR, 2002-04-04
December, 2008 FDA 483 Eye Bank For Sight Restoration Inc. - Form 483, 2008-12-30
July, 2015 FDA 483 Siemens Shanghai Medical Equipment Ltd. - Form 483, 2015-07-23
November, 2006 EIR Vitrolife Sweden AB - EIR, 2006-11-02
July, 2014 FDA 483 Shantou Chaonan Liangying Hegao Plastic Toy Factory - Form 483, 2014-07-17
March, 2015 FDA 483 Breas Medical AB - Form 483, 2015-03-05
April, 2001 EIR Nalge Nunc International Corporation - EIR, 2001-04-23
May, 2001 FDA 483 New York Blood Center, Inc. - Form 483, 2001-05-21
January, 2002 FDA 483 Response NYU Hospitals Center - Form 483R, 2002-03-28
August, 2009 FDA 483 New York Blood Center, Inc. - Form 483, 2009-08-13
August, 2008 FDA 483 Cayuga Medical Center at Ithaca, Inc. - Form 483, 2008-08-28
June, 2002 FDA 483 Aesculap AG - Form 483, 2002-06-13
June, 2014 FDA 483 Vasomedical Inc - Form 483, 2014-06-03
July, 2002 FDA 483 Response New York Blood Center Enterprises - Form 483R, 2002-07-26
September, 2003 FDA 483 Thommen Medical AG - Form 483, 2003-09-18
June, 2002 FDA 483 ESKA Implants GmbH & Co. - Form 483, 2002-06-20
April, 2001 FDA 483 Response New York Blood Center Enterprises - Form 483R, 2001-06-21
July, 2014 FDA 483 Wuhan Strong Electronics Co Ltd - Form 483, 2014-07-24
May, 2011 FDA 483 Mini Lap Technologies Inc. - Form 483, 2011-05-18
September, 2002 EIR New York Firefighters Skin Bank New York Presbyterian Hosp - EIR, 2002-09-20
September, 2003 EIR Thommen Medical, AG - EIR, 2003-10-17
May, 2001 FDA 483 Response New York Blood Center, Inc. - Form 483R, 2001-08-15
March, 2000 EIR New York Blood Center Enterprises - EIR, 2000-03-20
April, 2001 FDA 483 New York Blood Center Enterprises - Form 483, 2001-04-03
March, 2003 EIR NYU Hospitals Center - EIR, 2003-03-12
September, 2003 FDA 483 Thommen Medical, AG - Form 483, 2003-09-18
July, 2009 FDA 483 Response Merck Kommanditgesellschaft auf Aktien - Form 483R, 2009-09-18
October, 2012 FDA 483 Creaspine SAS - Form 483, 2012-10-18
January, 2002 EIR NYU Hospitals Center - EIR, 2002-01-18
July, 2002 FDA 483 New York Blood Center Enterprises - Form 483, 2002-07-09
March, 2004 EIR NYU Hospitals Center - EIR, 2004-03-31
April, 2015 FDA 483 Biochemical Diagnostics Inc - Form 483, 2015-04-28
October, 2014 FDA 483 Misonix, Inc. - Form 483, 2014-10-10
October, 2011 FDA 483 Stemsave , Inc. - Form 483, 2011-10-07
July, 2009 EIR Merck Kommanditgesellschaft auf Aktien - EIR, 2009-07-02
November, 2002 FDA 483 Rozinn Electronics Inc - Form 483, 2002-11-07
May, 2001 EIR New York Blood Center, Inc. - EIR, 2001-05-21
February, 2001 EIR Laerdal Medical A/S - EIR, 2001-02-08
September, 2012 EIR IVF New York - EIR, 2023-08-16
August, 2008 EIR IVF New York - EIR, 2008-08-16

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more